Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers
Status: | Terminated |
---|---|
Conditions: | Ovarian Cancer, Women's Studies |
Therapuetic Areas: | Oncology, Reproductive |
Healthy: | No |
Age Range: | 19 - Any |
Updated: | 5/12/2018 |
Start Date: | July 2015 |
End Date: | April 2018 |
Quality of Life Outcomes From a Peer-to-Peer Support Program for Women With Gynecologic Cancer
This pilot clinical trial studies a peer-to-peer support program in improving quality of life
outcomes in patients with gynecologic cancer and their caregivers. Peer-to-peer support and
mentoring may help improve quality of life and reduce symptoms of distress in gynecologic
cancer patients and their families.
outcomes in patients with gynecologic cancer and their caregivers. Peer-to-peer support and
mentoring may help improve quality of life and reduce symptoms of distress in gynecologic
cancer patients and their families.
PRIMARY OBJECTIVES:
I. To test the feasibility and acceptability of a Woman-to-Woman (W2W) program for patients
with gynecologic cancer at City of Hope (COH). Address the following descriptive research
questions: were patients, mentors, and patients' family caregivers satisfied with the timing,
format, and content of the program? Did the program benefit patients, mentors, and patients'
family caregivers?
OUTLINE:
Patients participate in the W2W program for which they are matched with a trained mentor and
followed throughout treatment by phone, email, and/or in person.
After completion of study, patients are followed up at 6 and 12 months.
I. To test the feasibility and acceptability of a Woman-to-Woman (W2W) program for patients
with gynecologic cancer at City of Hope (COH). Address the following descriptive research
questions: were patients, mentors, and patients' family caregivers satisfied with the timing,
format, and content of the program? Did the program benefit patients, mentors, and patients'
family caregivers?
OUTLINE:
Patients participate in the W2W program for which they are matched with a trained mentor and
followed throughout treatment by phone, email, and/or in person.
After completion of study, patients are followed up at 6 and 12 months.
Inclusion Criteria:
- PATIENT PARTICIPANTS
- Patients with newly diagnosed or recurrent gynecologic cancer (ovarian, uterine,
cervical, vaginal, vulvar) actively undergoing treatment (chemotherapy, surgery, or
radiation therapy) at COH (including Duarte and South Pasadena campuses)
- English-speaking patients
- PEER MENTORS
- Peer mentors will be past gynecologic cancer patients not currently undergoing
treatment for their cancer, and considered without evidence of disease
- Over age 18
- PEER MENTORS: English-speaking patients
- This study is open to patients of all races and ethnicities
Exclusion Criteria:
- PEER MENTORS:
- Major psychiatric disease
- Currently undergoing treatment for active gynecologic cancer
We found this trial at
1
site
Duarte, California 91010
Principal Investigator: Thanh H. Dellinger, MD
Phone: 800-826-4673
Click here to add this to my saved trials